The present invention concerns formulations that provide for the transdermal delivery of canabinoid(s) in therapeutically effective amounts without the need for phospholipids or harsh irritating penetration enhancers while simultaneously delivering skin protecting/enhancing ingredients topically to the top of the skin for preventing and treating skin conditions and/or enhancing the appearance of skin.
